USFDA accepted triple drug FDC empagliflozin, linagliptin and metformin extended release (XR) for the treatment of adults with type 2 diabetes
Posted on06 Jun 2019
Comments0
Boehringer Ingelheim and Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has accepted the New Drug Application... Read More